Atrium iCAST Iliac Stent Pivotal Study

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

May 31, 2014

Conditions
Peripheral Vascular Disease
Interventions
DEVICE

iCAST covered stent

Iliac stent implantation

Trial Locations (25)

17011

Holy Spirit Cardiovascular Institute, Camp Hill

27710

Duke University Medical Center, Durham

30308

Emory University Hospital Midtown, Atlanta

30309

Piedmont Hospital Research Institute, Atlanta

37934

Tennova Healthcare - Turkey Creek Medical Center, Knoxville

39401

Forest General Hospital, Hattiesburg

40202

University of Louisville, Louisville

43214

MidWest Cardiology Research Foundation, Columbus

44106

University Hospitals, Case Medical Center, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45219

Lindner Clinical Trial Center, Cincinnati

46202

Krannert Institute of Cardiology, Indianapolis

57108

North Central Heart Institute, Sioux Falls

60611

Northwestern University, Chicago

64132

Kansas City Heart Foundation, Kansas City

70121

Ochsner Clinic Foundation, New Orleans

70360

Terrebonne General Medical Center, Houma

72205

University of Arkansas for Medical Sciences, Little Rock

75231

Cardiovascular Research Institute of Dallas, Dallas

77030

The Methodist Hospital, Houston

94040

Fogarty Clincal Research Incorporated, Mountain View

95817

University of California, Davis, Sacramento

02114

Mass General Hospital, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

Unknown

Herzzentrum Bad Krozingen, Bad Krozingen

Sponsors
All Listed Sponsors
lead

Atrium Medical Corporation

INDUSTRY

NCT00593385 - Atrium iCAST Iliac Stent Pivotal Study | Biotech Hunter | Biotech Hunter